BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33221554)

  • 1. Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy.
    Roth E; Benoit S; Quentin B; Lam B; Will S; Ma M; Heeley N; Darwish T; Shrestha Y; Gribble F; Reimann F; Pshenichnaya I; Yeo G; Baker DJ; Trevaskis JL; Blouet C
    Mol Metab; 2021 Jan; 43():101118. PubMed ID: 33221554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression.
    Wagner S; Brierley DI; Leeson-Payne A; Jiang W; Chianese R; Lam BYH; Dowsett GKC; Cristiano C; Lyons D; Reimann F; Gribble FM; Martinez de Morentin PB; Yeo GSH; Trapp S; Heisler LK
    Mol Metab; 2023 Feb; 68():101665. PubMed ID: 36592795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats.
    Mhalhal TR; Washington MC; Newman K; Heath JC; Sayegh AI
    Physiol Behav; 2017 Oct; 179():191-199. PubMed ID: 28647503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice.
    Hornigold DC; Roth E; Howard V; Will S; Oldham S; Coghlan MP; Blouet C; Trevaskis JL
    Appetite; 2018 Aug; 127():334-340. PubMed ID: 29782892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
    Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
    Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.
    Anderberg RH; Richard JE; Eerola K; López-Ferreras L; Banke E; Hansson C; Nissbrandt H; Berqquist F; Gribble FM; Reimann F; Wernstedt Asterholm I; Lamy CM; Skibicka KP
    Diabetes; 2017 Apr; 66(4):1062-1073. PubMed ID: 28057699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.
    Reiner DJ; Mietlicki-Baase EG; McGrath LE; Zimmer DJ; Bence KK; Sousa GL; Konanur VR; Krawczyk J; Burk DH; Kanoski SE; Hermann GE; Rogers RC; Hayes MR
    J Neurosci; 2016 Mar; 36(12):3531-40. PubMed ID: 27013681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents.
    Yang Q; Zhou F; Tang X; Wang J; Feng H; Jiang W; Jin L; Jiang N; Yuan Y; Han J; Yan Z
    Eur J Med Chem; 2022 Apr; 233():114214. PubMed ID: 35231829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK stimulation of GLP-1 neurons involves α1-adrenoceptor-mediated increase in glutamatergic synaptic inputs.
    Hisadome K; Reimann F; Gribble FM; Trapp S
    Diabetes; 2011 Nov; 60(11):2701-9. PubMed ID: 21885869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance.
    Reiner DJ; Leon RM; McGrath LE; Koch-Laskowski K; Hahn JD; Kanoski SE; Mietlicki-Baase EG; Hayes MR
    Neuropsychopharmacology; 2018 Feb; 43(3):627-637. PubMed ID: 28920591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.
    Fortin SM; Lipsky RK; Lhamo R; Chen J; Kim E; Borner T; Schmidt HD; Hayes MR
    Sci Transl Med; 2020 Mar; 12(533):. PubMed ID: 32132220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation.
    Costa A; Ai M; Nunn N; Culotta I; Hunter J; Boudjadja MB; Valencia-Torres L; Aviello G; Hodson DJ; Snider BM; Coskun T; Emmerson PJ; Luckman SM; D'Agostino G
    Mol Metab; 2022 Jan; 55():101407. PubMed ID: 34844019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease.
    Han C; Sun Y; Yang Q; Zhou F; Chen X; Wu L; Sun L; Han J
    Mol Pharm; 2021 Aug; 18(8):2906-2923. PubMed ID: 34240881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system.
    Richard JE; Anderberg RH; Göteson A; Gribble FM; Reimann F; Skibicka KP
    PLoS One; 2015; 10(3):e0119034. PubMed ID: 25793511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence.
    Richard JE; Farkas I; Anesten F; Anderberg RH; Dickson SL; Gribble FM; Reimann F; Jansson JO; Liposits Z; Skibicka KP
    Endocrinology; 2014 Nov; 155(11):4356-67. PubMed ID: 25116706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
    Elvert R; Herling AW; Bossart M; Weiss T; Zhang B; Wenski P; Wandschneider J; Kleutsch S; Butty U; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Lorenz M; Keil S; Larsen PJ
    Diabetes Obes Metab; 2018 Aug; 20(8):1836-1851. PubMed ID: 29938884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient sensing in the nucleus of the solitary tract mediates non-aversive suppression of feeding via inhibition of AgRP neurons.
    Tsang AH; Nuzzaci D; Darwish T; Samudrala H; Blouet C
    Mol Metab; 2020 Dec; 42():101070. PubMed ID: 32898712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.